ArticleScientific reports2025
Association of miR-938 rs2505901 T > C polymorphism with reduced risk of venous malformations in a Chinese population.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Venous malformations are a common congenital vascular disorder. MicroRNAs are micro non-coding RNAs that are responsible for regulating the expression of genes after transcription. This study aimed to investigate the relationship between miR-938 rs2505901 T > C polymorphism and venous malformations. We collected blood samples from 1,113 patients with venous malformations and 1,158 members of the control group. TaqMan genotyping of miR-938 rs2505901 T > C was performed by real-time fluorescence quantitative polymerase chain reaction. We found the miR-938 rs2505901 T > C polymorphism was significantly associated with reduced risk of venous malformations in children [CC vs. TT: adjusted OR = 0.56, 95% confidence interval (CI) = 0.33-0.94, P = 0.027; CC vs. TT/TC: adjusted OR = 0.56, 95% CI = 0.33-0.93, P = 0.026]. We categorized venous malformations into six subtypes: head, neck, trunk, upper extremity, lower extremity, and multisite. Stratified analysis of rs2505901 T > C and venous malformations at different sites showed that the rs2505901 T > C polymorphism was significantly associated with a reduced risk of venous malformations occurring in the head. [Crude OR = 0.37, 95% CI = 0.17-0.82, P = 0.014; adjusted OR = 0.40, 95% CI = 0.17-0.92, P = 0.031]. The miR-938 rs2505901 T > C polymorphism was significantly associated with a reduced risk of venous malformations in children, and rs2505901 T > C was significantly associated with a reduced risk of venous malformations occurring in the head; the underlying mechanisms of venous malformations still need to be further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.